Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH9N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,371
Award facts
- Contract value 100% obligated
- $3,370.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,370.72 by the Defense Logistics Agency on January 14, 2026, for the supply of Xeljanz XR 11 mg tablets (30-count units). The contract, which is not set-aside and competitively awarded, carries a firm fixed-price structure with an ultimate completion date of January 15, 2026. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent IDC with the Defense Logistics Agency. The company supplies a broad portfolio of pharmaceutical products and medical commodities—including specialty medications, vaccines, and medical devices across multiple therapeutic domains—to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen to continue serving as a critical vendor in federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26FJH9N?
SPE2DR26FJH9N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH9N worth?
The government has obligated $3,371 on SPE2DR26FJH9N.
Is contract SPE2DR26FJH9N an order under another contract?
Yes. SPE2DR26FJH9N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH9N competed?
The extent of competition for SPE2DR26FJH9N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award